Contact
searchSearch
HMP Global

Atopic Dermatitis Topic Center

Featured

News
Machine Learning Identifies Potential Dual-Target Compounds for Atopic Dermatitis
05/05/2026
Jessica Garlewicz
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling may accelerate the discovery of novel therapies for atopic dermatitis by identifying compounds that simultaneously activate key anti-inflammatory pathways.
Machine learning–based modeling...
05/05/2026
The Dermatologist
News
Cutaneous Pain in Atopic Dermatitis Linked to Higher Psychological Burden
05/05/2026
Jessica Garlewicz
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic dermatitis is strongly associated with increased anxiety, depression, stigmatization, and impaired quality of life.
Cutaneous pain in atopic...
05/05/2026
The Dermatologist
News
POEM Scores Align With Clinical Severity and Treatment Intensity in Pediatric Atopic Dermatitis
05/05/2026
Jessica Garlewicz
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema Measure (POEM) may provide a practical and reliable assessment of disease severity in pediatric atopic dermatitis.
The Patient-Oriented Eczema...
05/05/2026
The Dermatologist
AD
News
Upadacitinib 30 mg Emerges as Most Effective Oral JAK Inhibitor for Moderate-to-Severe Atopic Dermatitis in Bayesian Meta-Analysis
03/31/2026
Riya Gandhi, MA
Comparative data across 9 randomized trials position upadacitinib at the top for skin clearance and itch reduction.
Comparative data across 9 randomized trials position upadacitinib at the top for skin clearance and itch reduction.
Comparative data across 9...
03/31/2026
The Dermatologist
AD
News
Upadacitinib 30 mg Ranks Most Effective Among Targeted Therapies for Atopic Dermatitis Without Topical Corticosteroids
03/31/2026
Riya Gandhi, MA
Updated network meta-analysis places upadacitinib at the top for multiple efficacy endpoints, including skin clearance and itch control.
Updated network meta-analysis places upadacitinib at the top for multiple efficacy endpoints, including skin clearance and itch control.
Updated network meta-analysis...
03/31/2026
The Dermatologist
News
Achieving Optimal Skin and Itch Targets Drives Superior Quality-of-Life Outcomes in Atopic Dermatitis
03/30/2026
Riya Gandhi, MA
Phase 3 data show patients reaching stringent treatment targets experience markedly greater improvements in sleep, pain, and mental health.
Phase 3 data show patients reaching stringent treatment targets experience markedly greater improvements in sleep, pain, and mental health.
Phase 3 data show patients...
03/30/2026
The Dermatologist
Atopic dermatitis
News
Upadacitinib Achieves Consistent Skin Clearance Across Body Regions in Real-World AD-VISE Study
03/30/2026
Riya Gandhi, MA
Real-world data show robust and consistent skin clearance with upadacitinib across body regions, regardless of prior biologic exposure.
Real-world data show robust and consistent skin clearance with upadacitinib across body regions, regardless of prior biologic exposure.
Real-world data show robust and...
03/30/2026
The Dermatologist
Atopic dermatitis
News
Upadacitinib Delivers Rapid, Sustained Improvements in Severe Atopic Dermatitis in Real-World Cohort
03/30/2026
Riya Gandhi, MA
A retrospective study shows high response rates and favorable safety in heavily pretreated patients, including those with difficult-to-treat anatomical involvement.
A retrospective study shows high response rates and favorable safety in heavily pretreated patients, including those with difficult-to-treat anatomical involvement.
A retrospective study shows high...
03/30/2026
The Dermatologist
News
Upadacitinib Demonstrates Consistent Long-Term Safety Across Age Groups in Atopic Dermatitis Over 6 Years
03/30/2026
Riya Gandhi, MA
Pooled phase 3 data show stable safety outcomes with upadacitinib across age groups, with dose considerations emerging in older patients.
Pooled phase 3 data show stable safety outcomes with upadacitinib across age groups, with dose considerations emerging in older patients.
Pooled phase 3 data show stable...
03/30/2026
The Dermatologist
Atopic dermatitis
News
Component-Resolved Diagnostics May Enable Precision Allergen Profiling in Atopic Dermatitis
03/19/2026
Jessica Garlewicz
Component-resolved diagnostics may offer a more precise approach to allergen assessment in atopic dermatitis, according to a review examining its potential role in personalized disease management.
Component-resolved diagnostics may offer a more precise approach to allergen assessment in atopic dermatitis, according to a review examining its potential role in personalized disease management.
Component-resolved diagnostics...
03/19/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist

Multimedia

Fall Clinical AD Roundtable
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following Fall Clinical
11/03/2022
Mona Shahriari, MD, FAAD
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs...
11/03/2022
The Dermatologist
Roundtable AAD
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAD
08/15/2022
Amy S. Paller, MD, MS
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
Drs Friedman, Lio, Shi and Kirkorian
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAAAI
07/15/2022
Adam Friedman, MD; Peter Lio, MD, FAAD; Vivian Shi, MD
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs...
07/15/2022
The Dermatologist
Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Shawn Kwatra, MD
Videos
ICYM RAD 2022: Dr Kwatra on Itch in Atopic Dermatitis
04/13/2022
Shawn Kwatra, MD
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual...
04/13/2022
The Dermatologist
Raj Chovatiya
Videos
Prurigo Nodularis: When Type 2 Inflammation Meets Neural Sensitization
05/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explores the neuroimmune mechanisms driving prurigo nodularis, highlighting the role of type 2 inflammation, IL-31–mediated itch signaling, and cytokines like IL-4 and IL-13 in fibrosis and neuronal sensitization.
Dr Raj Chovatiya explores the neuroimmune mechanisms driving prurigo nodularis, highlighting the role of type 2 inflammation, IL-31–mediated itch signaling, and cytokines like IL-4 and IL-13 in fibrosis and neuronal sensitization.
Dr Raj Chovatiya explores the...
05/01/2026
The Dermatologist
Adam Sutton, MD, MBA
Videos
Recap: Surgical Reconstruction Planning for Optimal Outcomes
04/27/2026
Riya Gandhi, MA
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton approaches complex skin cancer reconstructions.
Discover how Dr Adam Sutton...
04/27/2026
The Dermatologist
John Zampella, MD, FAAD
Videos
Considerations for Treatment Decision-Making
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
This session explores evidence-based approaches to treatment selection for genital and intertriginous psoriasis, emphasizing the role of nonsteroidal and systemic therapies. Learn how shared decision-making and patient-centered goal setting...
This session explores evidence-based approaches to treatment selection for genital and intertriginous psoriasis, emphasizing the role of nonsteroidal and systemic therapies. Learn how shared decision-making and patient-centered goal setting...
This session explores...
04/16/2026
The Dermatologist
Michael Payette, MD, MBA, FAAD
Videos
Impact on Patient Quality of Life and Interpersonal Relationships
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
Experts examine the multidimensional burden of genital and intertriginous psoriasis, including effects on intimacy, daily functioning, and psychological well-being. Gain insight into the clinical consequences of delayed diagnosis and the...
Experts examine the multidimensional burden of genital and intertriginous psoriasis, including effects on intimacy, daily functioning, and psychological well-being. Gain insight into the clinical consequences of delayed diagnosis and the...
Experts examine the...
04/16/2026
The Dermatologist
Shehla Admani, MD
Videos
Diagnosis and Clinician–Patient Conversations
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
This discussion outlines best practices for the physical diagnosis of genital and intertriginous psoriasis, including the role of comprehensive skin examinations and considerations for biopsy in cases of diagnostic uncertainty. Experts also...
This discussion outlines best practices for the physical diagnosis of genital and intertriginous psoriasis, including the role of comprehensive skin examinations and considerations for biopsy in cases of diagnostic uncertainty. Experts also...
This discussion outlines best...
04/16/2026
The Dermatologist
Melodie Young, MSN A/GNP-c
Videos
Treatment Landscape and Unmet Needs
04/16/2026
Shehla Admani, MD; Michael J. Payette, MD, MBA, FAAD; Melodie Young, MSN, GNP; John Zampella, MD, FAAD
An expert panel reviews the current evidence landscape for genital and intertriginous psoriasis, highlighting gaps in epidemiology, clinical guidance, and standardized classification that contribute to variability in care. Learn how...
An expert panel reviews the current evidence landscape for genital and intertriginous psoriasis, highlighting gaps in epidemiology, clinical guidance, and standardized classification that contribute to variability in care. Learn how...
An expert panel reviews the...
04/16/2026
The Dermatologist
Heberton
Videos
Managing EGFR Skin Toxicities
04/01/2026
Riya Gandhi, MA
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the...
04/01/2026
The Dermatologist
Amy paller
Videos
Disease Biology and Early Recognition in Atopic Dermatitis
04/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how...
04/01/2026
The Dermatologist
Joseph F. Merola, MD, MMSc, and Colby Evans, MD
Videos
Autoimmune Serologies in Dermatology
04/01/2026
Riya Gandhi, MA
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how...
04/01/2026
The Dermatologist
Melissa Mauskar, MD
Videos
Practical Pearls of Vulvar Dermatoses
04/01/2026
Riya Gandhi, MA
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses...
04/01/2026
The Dermatologist

From the Issue

Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Emma Guttman-Yassky, MD, PhD
Feature Story
Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod
10/10/2021
Peter Sonnenreich
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical...
10/10/2021
The Dermatologist
NEA Approved Features
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
NEA Approved Features
Quiz: Pain in Atopic Dermatitis
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Partner Approved
Get Eczema Wise During Eczema Awareness Month
10/16/2020
Lauren Mateja
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Feature Story
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
08/13/2020
Ana B. Rossi, MD, CMD; Brad Shumel, MD
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by...
08/13/2020
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
HSF-Reviewed Content
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist
MASTERCLASSES IN DERMATOLOGY FORUM
Redefining Remission and Low Disease Activity in Dermatology
10/06/2025
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an...
10/06/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist
HSF Reviewed Features
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
09/08/2025
Gretchen M. Roth, MD, FAAD; Precious A. Anyanwu
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve...
09/08/2025
The Dermatologist
April/May 2026 cover

Current Issue

May 2026
Volume 34
Issue 3
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use